MoonLake Immunotherapeutics (MLTX)
Nasdaq • MLTX • KY61559X1045
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 14.1% of free float sold short, 4 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
Market Cap
1.07b USD | # 4885 in US
Volume
1.71m shares | 22.23m USD
Shares Outstanding
85.11m
Free Float Shares
65.18% | 55.47m
